Speech clinical trials

Explore recruiting speech clinical trials.

Recruiting speech studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Speech trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase IIa randomized, double-blind, and placebo-controlled multicenter split body trial to determine safety, tolerability, and efficacy of repeated doses of ACOU085 for the prevention of hearing loss in testicular cancer patients receiving cisplatin

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2, Open-Label, Multicenter Trial with a Single Ascending Dose Cohort with Unilateral Intracochlear Injection Followed by a Bilateral Injection Expansion Cohort to Evaluate the Safety, Tolerability, and Efficacy of DB-OTO in Children and Infants with Biallelic hOTOF Mutations

Spain, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

An Evaluation of the Long Term Safety and Efficacy of AAVAnc80-hOTOF Gene Therapy in Individuals with Sensorineural Hearing Loss due to Otoferlin Gene (OTOF) Mutations

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Cognitive function after liver transplantation comparing Tacrolimus formulations

Germany

Therapeutic use (Phase IV) EU CTIS Study details

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Quality of Life

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants with Amyotrophic Lateral Sclerosis

Belgium, Netherlands, Poland, France, Germany, Ireland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Speech trials by city

Speech in Toronto Speech in Vancouver Speech in Montreal Speech in Calgary Speech in Edmonton Speech in Ottawa Speech in Winnipeg Speech in Quebec City Speech in Hamilton Speech in Kitchener Speech in London Speech in Halifax Speech in New York Speech in Los Angeles Speech in Chicago Speech in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease